Keersten M Ricks
Overview
Explore the profile of Keersten M Ricks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cote C, Mlynek K, Klimko C, Biryukov S, Mou S, Hunter M, et al.
Emerg Infect Dis
. 2024 Sep;
30(10):2056-2069.
PMID: 39320153
In the United States in 2021, an outbreak of 4 cases of Burkholderia pseudomallei, the etiologic agent of melioidosis and a Tier One Select Agent (potential for deliberate misuse and...
2.
Cohen C, Balinandi S, Kuehne A, Rock M, Bonagofski L, Ricks K, et al.
J Infect Dis
. 2024 Sep;
PMID: 39248523
Evaluating the adaptive immune responses to natural infection with Crimean-Congo hemorrhagic fever (CCHF) virus (CCHFV) in human survivors is critical to the development of medical countermeasures. However, the correlates of...
3.
Mucker E, Freyn A, Bixler S, Cizmeci D, Atyeo C, Earl P, et al.
Cell
. 2024 Sep;
187(20):5540-5553.e10.
PMID: 39236707
In 2022, mpox virus (MPXV) spread worldwide, causing 99,581 mpox cases in 121 countries. Modified vaccinia Ankara (MVA) vaccine use reduced disease in at-risk populations but failed to deliver complete...
4.
Scherr T, Douglas C, Schaecher K, Schoepp R, Ricks K, Shoemaker C
Diagnostics (Basel)
. 2024 Jun;
14(12).
PMID: 38928705
In recent years, infectious disease diagnosis has increasingly turned to host-centered approaches as a complement to pathogen-directed ones. The former, however, typically requires the interpretation of complex multiple biomarker datasets...
5.
Garrison A, Moresco V, Zeng X, Cline C, Ward M, Ricks K, et al.
Nat Commun
. 2024 Feb;
15(1):1722.
PMID: 38409240
Crimean-Congo hemorrhagic fever virus (CCHFV) is a WHO priority pathogen. Antibody-based medical countermeasures offer an important strategy to mitigate severe disease caused by CCHFV. Most efforts have focused on targeting...
6.
Zumbrun E, Zak S, Lee E, Bowling P, Ruiz S, Zeng X, et al.
Viruses
. 2023 Dec;
15(12).
PMID: 38140582
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the worldwide COVID-19 pandemic. Animal models are extremely helpful for testing vaccines and therapeutics and for dissecting the...
7.
Taylor K, Ricks K, Kuehnert P, Eick-Cost A, Scheckelhoff M, Wiesen A, et al.
AJPM Focus
. 2023 Oct;
2(4):100141.
PMID: 37885754
Introduction: Reported confirmed cases represent a small portion of overall true cases for many infectious diseases. The undercounting of true cases can be considerable when a significant portion of infected...
8.
Davis I, Payne J, Olguin V, Sanders M, Clements T, Stefan C, et al.
Front Microbiol
. 2023 Sep;
14:1243523.
PMID: 37744911
Human monkeypox (mpox) has recently become a global public health emergency; however, assays that detect mpox infection are not widely available, largely due to cross-reactivity within the genus. Immunoassay development...
9.
Golden J, Fitzpatrick C, Suschak J, Clements T, Ricks K, Sanchez-Lockhart M, et al.
Virus Res
. 2023 Jul;
334:199173.
PMID: 37459918
Crimean-Congo hemorrhagic fever (CCHF) is a World Health Organization prioritized disease because its broad distribution and severity of disease make it a global health threat. Despite advancements in preclinical vaccine...
10.
Bixler S, Stefan C, Jay A, Rossi F, Ricks K, Shoemaker C, et al.
Viruses
. 2022 May;
14(5).
PMID: 35632755
The emergence of SARS-CoV-2 and the subsequent pandemic has highlighted the need for animal models that faithfully replicate the salient features of COVID-19 disease in humans. These models are necessary...